S-adenosylmethionine synthetase (AdoMetS), Active, E. coli Recombinant
Methionine adenosyltransferase, AdoMet synthetase, MAT
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P0A817 |
---|---|
Concentration | 3.6 mg/ml |
Calculated MW | 43 kDa |
Gene ID | 93779055;945389 |
---|---|
Other Names | Methionine adenosyltransferase, AdoMet synthetase, MAT |
Gene Source | Human |
Source | E.coli |
Assay&Purity | SDS-PAGE;> 90% |
Recombinant | Yes |
Target/Specificity | S-adenosylmethionine synthase |
Format | Liquid |
Storage | -80°C;Proprietary formulation |

Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
S-Adenosylmethionine synthase, (AdoMetS), (E.C. 2.5.1.6) catalyzes the formation of S-adenosylmethionine (AdoMet) from methionine and ATP. The overall synthetic reaction is composed of two sequential steps, AdoMet formation and the subsequent tripolyphosphate hydrolysis which occurs prior to release of AdoMet from the enzyme. BioVision’s active AdoMetS is suitable for functional assays, high-throughput screening and preclinical studies in drug discovery.

If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.